Computer model helps tailor blood pressure drugs for liver patients
NCT ID NCT07397481
First seen Feb 19, 2026 · Last updated Apr 25, 2026 · Updated 9 times
Summary
This study tested whether a computer program (Simcyp) could predict safe and effective doses of two blood pressure drugs (nebivolol and carvedilol) in 40 people with liver cirrhosis and high blood pressure. Participants were randomly assigned to one of the drugs at the computer-predicted dose and monitored for three months. The goal was to see if this approach could better manage blood pressure and reduce side effects in this complex patient group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kafrelsheikh University
Cairo, Egypt, Egypt
Conditions
Explore the condition pages connected to this study.